Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 45
Growth YoY: +18.8%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 1,201–1,250 of 1,346 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00005591	Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas	withdrawn	Phase 2	0	University of Alabama at BirminghamOTHER	0	Dec 13, 2013	clinicaltrials
NCT01659502	Investigator's Initiated Phase II Study for Pancreatic Cancer Patients	unknown	Phase 2	10	Tiltan Pharma Ltd.INDUSTRY	1	Dec 5, 2013	clinicaltrials